These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 28941925)

  • 21. Prostate-specific antigen (PSA) concentrations in hypogonadal men during 6 years of transdermal testosterone treatment.
    Raynaud JP; Gardette J; Rollet J; Legros JJ
    BJU Int; 2013 May; 111(6):880-90. PubMed ID: 23294726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low testosterone is associated with an increased risk of MACE lethality in subjects with erectile dysfunction.
    Corona G; Monami M; Boddi V; Cameron-Smith M; Fisher AD; de Vita G; Melani C; Balzi D; Sforza A; Forti G; Mannucci E; Maggi M
    J Sex Med; 2010 Apr; 7(4 Pt 1):1557-64. PubMed ID: 20102478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obesity and hypogonadism are associated with an increased risk of predominant Gleason 4 pattern on radical prostatectomy specimen.
    Neuzillet Y; Raynaud JP; Lebret T; Pichon A; Radulescu C; Molinie V; Botto H
    Horm Mol Biol Clin Investig; 2015 Jun; 22(3):101-9. PubMed ID: 26047422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship between total testosterone levels and prostate cancer: a review of the continuing controversy.
    Klap J; Schmid M; Loughlin KR
    J Urol; 2015 Feb; 193(2):403-13. PubMed ID: 25260832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes of Prostate Biopsy in Men with Hypogonadism Prior or During Testosterone Replacement Therapy.
    Shoskes DA; Barazani Y; Fareed K; Sabanegh E
    Int Braz J Urol; 2015; 41(6):1167-71. PubMed ID: 26742976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial.
    Marks LS; Mazer NA; Mostaghel E; Hess DL; Dorey FJ; Epstein JI; Veltri RW; Makarov DV; Partin AW; Bostwick DG; Macairan ML; Nelson PS
    JAMA; 2006 Nov; 296(19):2351-61. PubMed ID: 17105798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Higher sex hormone-binding globulin and lower bioavailable testosterone are related to prostate cancer detection on prostate biopsy.
    García-Cruz E; Carrión Puig A; García-Larrosa A; Sallent A; Castañeda-Argáiz R; Piqueras M; Ribal MJ; Leibar-Tamayo A; Romero-Otero J; Alcaraz A
    Scand J Urol; 2013 Aug; 47(4):282-9. PubMed ID: 23181478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of aromatase inhibition in hypogonadal older men: a randomized, double-blind, placebo-controlled trial.
    Burnett-Bowie SA; Roupenian KC; Dere ME; Lee H; Leder BZ
    Clin Endocrinol (Oxf); 2009 Jan; 70(1):116-23. PubMed ID: 18616708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is there a protective role of testosterone against high-grade prostate cancer? Incidence and severity of prostate cancer in 553 patients who underwent prostate biopsy: a prospective data register.
    Yassin A; Salman M; Talib RA; Yassin DJ
    Aging Male; 2017 Jun; 20(2):125-133. PubMed ID: 28282997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low serum testosterone is a predictor of high-grade disease in patients with prostate cancer.
    Albuquerque GAML; Guglielmetti GB; Barbosa JABA; Pontes J; Fazoli AJC; Cordeiro MD; Coelho RF; Carvalho PA; Gallucci FP; Padovani GP; Park R; Cury J; Nonemacher H; Srougi M; Nahas WC
    Rev Assoc Med Bras (1992); 2017 Aug; 63(8):704-710. PubMed ID: 28977109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Role of Testosterone Therapy in the Setting of Prostate Cancer.
    Rodriguez KM; Pastuszak AW; Khera M
    Curr Urol Rep; 2018 Jun; 19(8):67. PubMed ID: 29961247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Testosterone replacement therapy does not promote priapism in hypogonadal men with sickle cell disease: 12-month safety report.
    Morrison BF; Reid M; Madden W; Burnett AL
    Andrology; 2013 Jul; 1(4):576-82. PubMed ID: 23606509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do androgens regulate growth hormone-binding protein in adult man?
    Ip TP; Hoffman DM; O'Sullivan AJ; Leung KC; Ho KK
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1278-82. PubMed ID: 7714101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate cancer: Testosterone therapy for hypogonadal men with prostate cancer.
    Catarinicchia SP; Crawford ED
    Nat Rev Urol; 2016 Sep; 13(9):497-8. PubMed ID: 27431338
    [No Abstract]   [Full Text] [Related]  

  • 35. Increased incidence of diagnosed depressive illness in hypogonadal older men.
    Shores MM; Sloan KL; Matsumoto AM; Moceri VM; Felker B; Kivlahan DR
    Arch Gen Psychiatry; 2004 Feb; 61(2):162-7. PubMed ID: 14757592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pilot study on the effects of testosterone in hypogonadal aging male patients with Alzheimer's disease.
    Tan RS; Pu SJ
    Aging Male; 2003 Mar; 6(1):13-7. PubMed ID: 12809076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Occult prostate cancer in men with low serum testosterone levels.
    Morgentaler A; Bruning CO; DeWolf WC
    JAMA; 1996 Dec; 276(23):1904-6. PubMed ID: 8968017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Testosterone Therapy after Radiation Therapy for Low, Intermediate and High Risk Prostate Cancer.
    Pastuszak AW; Khanna A; Badhiwala N; Morgentaler A; Hult M; Conners WP; Sarosdy MF; Yang C; Carrion R; Lipshultz LI; Khera M
    J Urol; 2015 Nov; 194(5):1271-6. PubMed ID: 26025500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High levels of circulating testosterone are not associated with increased prostate cancer risk: a pooled prospective study.
    Stattin P; Lumme S; Tenkanen L; Alfthan H; Jellum E; Hallmans G; Thoresen S; Hakulinen T; Luostarinen T; Lehtinen M; Dillner J; Stenman UH; Hakama M
    Int J Cancer; 2004 Jan; 108(3):418-24. PubMed ID: 14648709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Associations of pretreatment serum total testosterone measurements with pathology-detected Gleason score cancer.
    Porcaro AB; Petrozziello A; Ghimenton C; Migliorini F; Sava T; Caruso B; Romano M; Cavalleri S; Artibani W
    Urol Int; 2014; 93(3):269-78. PubMed ID: 24334919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.